DCGI Classifies 112 Anesthesiology Devices Under Medical Devices Rules

New Delhi : The Drug Controller General (India) has classified 112 medical devices related to anesthesiology, which is used in taking care of a patient before, during and after surgery, under Medical Devices Rules.

The devices including pulse oximeter, anesthesia machine, tracheostomy kit, oxygen, air and nitrous oxide breathing gas mixer, and epidural anaesthesia kit have been classified under risk class C. It may be noted that the government had earlier this week announced capping of trade margins for five medical devices including pulse oximeter.

Aerosol face mask, aerosol inhalation monitor, airway pressure or oxygen monitor device among others have been classified under risk class B. Devices including anaesthesia catheter luer connector, anaesthesia depth simulator, anaesthesia instrument table and others have been classified under risk class A.

Risk Class A is considered as lower risk, while Class B is low moderate risk and Class C is moderate high risk. The classification is based on the intended use of the device, risk associated with the device and other parameters specified under the Medical Devices Rules, 2017.

Of the devices classified under the new notice, almost 49 are under Risk Class A, and around 45 are under Risk Class B, while the rest are under Class C.

Accessories and components of medical devices imported as a system need not be registered separately. However, this does not debar from risk based classification of the accessories or components of medical devices, it said.

The anaesthetics and catheters of cardio respiratory devices manufacturing is supported by the Department of Pharmaceuticals under production linked incentive (PLI) scheme to boost domestic manufacturing.

The Central Drugs Standard Control Organisation (CDSCO) had earlier this month updated the list of medical device testing laboratories registered with the regulator to 14 across the country. There are more applicants which are under evaluation, said CDSCO.

  • Related Posts

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June